Kristin Stafford

Kristin Stafford is the Chief Financial Officer of Zymeworks, Inc., where she plays a pivotal role in overseeing the company's financial strategy and operations. Recently, she discussed Zymeworks' significant acquisition of Theravance Biopharma, highlighting the financing structure and the expected benefits from the deal, particularly regarding Yupelri royalties.